IDH2 and glioblastoma: However, some GBM studies that included both primary and secondary GBM patients suggested that TERT promoter mutations are independently associated with a negative prognosis.19, 20 We speculate that the prognostic value of TERT promoter mutations in relation to poor survival is partly due to the IDH status.